The high incidence of tuberculosis around the world and the inability of BCG to protect certain populations clearly indicate that an improved vaccine against tuberculosis is needed. A single antigen, the mycobacterial heat shock protein hsp65, is sufficient to protect BALB/c mice against challenge infection when administered as DNA vaccine in a threedose-based schedule. In order to simplify the vaccination schedule, we coencapsulated hsp65-DNA and trehalose dimicolate (TDM) into biodegradable poly(DL-lactide-co-glycolide) (PLGA) microspheres. BALB/c mice immunized with a single dose of DNA-hsp65/TDM-loaded microspheres produced high levels of IgG2a subtype antibody and high amounts of IFN-g in the supernatant of spleen cell cultures. DNA-hsp65/TDM-loaded microspheres were also able to induce high IFN-g production in bulk lung cells from challenged mice and confer protection as effective as that attained after three doses of naked DNA administration. This new formulation also allowed a ten-fold reduction in the DNA dose when compared to naked DNA. Thus, this combination of DNA vaccine and adjuvants with immunomodulatory and carrier properties holds the potential for an improved vaccine against tuberculosis. Gene Therapy (2003) 10, 678-685.
Introduction
Tuberculosis remains a threat for public health, killing around three million people a year. 1 Despite the fact that most cases can be cured with antibiotics, the treatment is long and patients relapse if chemotherapy is not continued for at least 6 months. 2 Thus, there is a consensus that a new, safe, and efficient vaccine is needed to control the disease. 3, 4 Vaccination by intramuscular injection of naked plasmid DNA encoding mycobacterial 65 kDa heat shock protein (hsp65) protected BALB/c mice against subsequent challenge with virulent Mycobacterium tuberculosis H37Rv strain. [5] [6] [7] Protection was attributed to the establishment of a cellular immune response dominated by antigen-specific T lymphocytes (TL) that both produced interferon-g and were cytotoxic towards infected cells. 8 In addition, in heavily infected mice, vaccination with hsp65-encoding DNA can switch the immune response from one that is relatively inefficient and produces bacterial stasis to one that kills bacteria, presenting pronounced therapeutic action. 9 Although the use of naked DNA is able to elicit an effective immune response in this experimental model of tuberculosis, the amount of plasmid required is very high. Thus, parallel tracks based on the method of delivery have been developed to candidate DNA vaccines. 10, 11 When DNA-hsp65 was administered in mice by gene gun, which targets the intracellular delivery of DNA-coated gold particles to the epidermis, a specific immune response was elicited with 100-fold less DNA than the amount used in intramuscular injection of naked DNA. However, the gene gun administration induced a Th2 pattern of immune response and did not protect mice against challenge infection.
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Biodegradable microspheres such as those based on polylactic polyglycolic copolymers (PLGA) have the potential to act as mediators of DNA transfection targeted to phagocytic cells such as macrophages, and to protect against biological degradation by nucleases. 13 PLGA is a biocompatible and biodegradable material with an extensive record of safe use in medicine, 14 and PLGA particles less than 10 mm in diameter are actively taken up by cells such as macrophages. 15 The entrapment of DNA-hsp65 into PLGA microspheres does not interfere with its functionality. When administered in BALB/c mice, DNA-hsp65-loaded microspheres were able to elicit specific immune response with IFN-g production, giving a ten-fold reduction in the DNA amount when compared to intramuscular injection of naked DNA-hsp65. However, DNA-loaded microspheres were also unable to protect mice against challenge. 16 This inability to confer protection against challenge could be associated with the reduction of the DNA amount administered and, consequently, the reduction of immunostimulatory CpG motifs. Immunomodulatory properties as induction of cytokine production and costimulatory molecules expression have been attributed to CpG motifs. 17 Thus, the entrapment of DNA plus an immunostimulant compound into PLGA microspheres could be an interesting strategy for vaccine formulation.
Trehalose 6,6 0 -dimycolate (TDM, cord factor) is a potent immunomodulator that is located on the external layer of the cell wall of mycobacteria. 18 The adjuvant effect of purified TDM on immune response has been recognized long ago. 19 Koike et al demonstrated that the use of TDM in combination with a recombinant human hepatitis B virus vaccine enhances both antibody production and cellular immune response against the antigen.
20 Moreover, we have previously shown that intratracheal administration of TDM-loaded microspheres in mice induced high levels of cytokines in lung cells and also high levels of nitric oxide in the supernatant of bronchoalveolar lavage cell cultures. 21 These immunostimulatory activities made TDM an attractive candidate for adjuvant use in a vaccine formulation.
In this work we evaluated the immune response elicited in BALB/c mice by microspheres containing DNA-hsp65 plus TDM, as well as the protection against M. tuberculosis challenge following a single-dose administration.
Results
Encapsulation efficiency and physical characteristics of DNA-hsp65/TDM-loaded microspheres Plasmid DNA was incorporated into PLGA microspheres by the double emulsion/solvent evaporation method. DNA encapsulation efficiency was 60%, corresponding to 6.0 mg of DNA/mg microspheres. As shown in Table 1 , laser diffractometry analysis indicates that particles were smaller than 5 mm.
hsp65 mRNA detection in different tissues by RT-PCR
In order to test the expression of the mycobacterial hsp65 following plasmid administration in mice, the presence of hsp65 mRNA in different tissues of pCDNA3-hsp65-vaccinated animals was analyzed by RT-PCR. Figure 1 shows the RT-PCR results in several tissues from mice killed 15 days following immunization with naked DNA or with DNA/TDM-loaded microspheres. Animals immunized with naked DNA (three doses of 100 mg of DNA) presented a band corresponding to mRNA for hsp65 in muscle and liver 15 days after the last injection, whereas mice immunized with DNA/TDM-loaded microspheres (one dose of 30 mg of DNA) presented a message for hsp65 in liver, muscle, draining LN, and spleen. Tissues from mice immunized with pCDNA3-hsp65 alone or irrelevant DNA entrapped into microspheres did not show any signs of a message for mycobacterial hsp65 (data not shown).
Histological analysis of the site of administration
The histological analysis of the site of administration shows that the microspheres form a depot after injection, promoting an infiltration of mononuclear cells ( Figure  2a ). However, 30 days after administration, the depot was completely cleared without signs of the presence of particles or tissue damage (Figure 2b ).
Profile of antibody production
Isotypes of antibodies raised by immunization with a single dose of pCDNA3-hsp65/TDM-loaded microspheres or with three doses of naked pCDNA3-hsp65 were determined by ELISA, using serum obtained 30 or 15 days after the last dose, respectively. Figure 3 shows that the enhanced antibody titers obtained from mice immunized with a single dose of pCDNA3-hsp65/TDMloaded microspheres were caused by high titers of IgG2a antibody specific to hsp65 antigen, while mice immunized with three doses of naked pCDNA3-hsp65 presented high levels of both IgG1 and IgG2a isotypes. A single dose of naked DNA was not effective to elicit specific antibody production (data not shown).
Cytokine production by spleen cells from immunized mice
The production of IFN-g, the main cytokine related to protection against tuberculosis, was evaluated in the culture supernatant of spleen cells from immunized mice. Similar to three doses of naked pCDNA3-hsp65, a single dose of pCDNA3-hsp65/TDM-loaded microspheres was able to induce high levels of IFN-g after in vitro restimulation with recombinant hsp65 (Figure 4 ). However, one dose of naked DNA does not elicit Tuberculosis protection by single-dose vaccine KM Lima et al significant IFN-g production and two doses of naked DNA elicit a small specific production, which is not enough to give protection to mice (data not shown).
Cytokine production in bulk lung cells homogenate from mice vaccinated and challenged with a virulent strain of M. tuberculosis
Thirty days after challenge, mice were killed and cytokine levels were measured in bulk lung cells homogenate. As shown in Figure 5 , mice immunized with pCDNA3-hsp65/TDM-loaded microspheres presented high levels of IFN-g. There was no statistically significant difference in IL-10 and IL-4 production among the groups (data not shown).
Protection against M. tuberculosis H37Rv replication in lungs of vaccinated BALB/c mice
As shown in Figure 6 , a single dose of pCDNA3-hsp65/ TDM-loaded microspheres was able to protect the animals against M. tuberculosis H37Rv as efficiently as three doses of naked pCDNA3-hsp65. There was a reduction in the CFU number of about 2 logs compared to control mice, which is similar to the reduction provided by BCG in this mouse strain, which therefore can be considered as good protection.
Discussion
Currently, many new vaccines are under development and there is a desire to simplify vaccination schedules by Tuberculosis protection by single-dose vaccine KM Lima et al decreasing the number of doses. 22 With this purpose, various substances have been added to vaccines and certain formulations have been devised in an attempt to render vaccines more effective. 23 Despite the success of naked DNA-hsp65-based vaccine to protect BALB/c mice against tuberculosis, it requires multiple doses of high amounts of plasmid for effective immunization. 7 To optimize this DNA vaccine, we used an approach where adjuvants with targeting and immunostimulatory properties prepared by microencapsulation techniques are administered in conjunction with the DNA-encoding antigen.
A formulation containing the DNA vaccine and TDM as immune stimulator, both carried by biodegradable microspheres, was developed. This technique allows the entrapment of both hydrophilic and hydrophobic [24] [25] [26] [27] Thus, when directly transfected in vivo, these cells may present Ag and display costimulatory surface molecules, providing the required signals for TL priming. In addition, after intramuscular injection, the microspheres form a depot, which recruits APC to the site of administration facilitating capture of particles and APC transfection. Moreover, in contrast to several new vaccine adjuvants that have been hampered by their unacceptable reactogenicity, PLGA microparticles used in this study are highly tissue compatible in the amount administered. In fact, PLA-derived polymers have been extensively used in humans as suture material as well as in drug delivery systems. 28 Histological analysis showed that the initial muscular depot totally disappeared 30 days after injection without tissue damage.
The ability of PLGA microspheres to release the entrapped plasmid slowly indicates that this system is also able to sustain the protein expression for a longer period without the need of a booster, compared to naked DNA administration. The RT-PCR data showed that the mRNA for hsp65 can be sustained for 15 days in muscle, liver, and also in secondary lymphoid organs such as draining LN and spleen, where TL priming occurs. However, after naked DNA administration, mRNA for hsp65 was detected only in muscle and liver, in the same period evaluated. After uptake of microspheres, the phagosome will suffer a maturation process with lysosome fusion and consequent decrease of pH. Although this phenomenon has no direct effect on the polymeric matrix, it may contribute to degrade the released DNA, impairing the transfection process. It has been demonstrated that TDM, in mycobacteria, inhibits the fusion process between lysosome and phagosome because of structural peculiarities that allow it to insert, organize, and orientate itself in the phagosome membrane. Owing to the prominence of the trehalose hydrophilic portion, there is an increase in hydration around the vesicle, providing a steric blockage to cellular fusion phenomena. 29 In the same fashion, TDM entrapped into microspheres could be released into the phagosome, blocking or delaying the fusion of lysosome, avoiding DNA degradation. Since there is no clear evidence about how DNA crosses over barriers such as nuclear membranes, phagosomes, and endosomes, TDM could allow more time for DNA to do this.
Regarding immune response, a marked shift was noted in the type of antibodies produced following vaccination with DNA-hsp65/TDM-loaded microspheres. This response was characterized by high levels of specific IgG2a, while mice immunized with naked DNA presented a mixed pattern of antibody production with high levels of both IgG1 and IgG2a. Cellular immune response was characterized by the production of cytokines, mainly IFN-g. Both naked DNA-hsp65 and DNA-hsp65/TDM-loaded microspheres were able to induce a high production of IFN-g by spleen cells. However, levels of IFN-g were high only in the lungs of challenged mice vaccinated with DNA-hsp65/TDMloaded microspheres. This profile could be attributed to TDM stimuli. Ryll et al 30 showed that TDM could trigger an innate immune response, which was evident by the proliferation of NK cells. It could also initiate an early immune response starting with the release of IFN-g leading to activation of macrophages, which was evident by up-regulation of MHC class II and CD1d1 expression. 30 Thus, TDM could provide optimal conditions to initiate an immune response, making it a valuable Th1-promoting component of a vaccine against tuberculosis.
A significant level of protection was observed both in mice vaccinated with naked DNA-hsp65 and DNAhsp65/TDM-loaded microspheres after challenge with a virulent strain of M. tuberculosis. It should be pointed out that the vaccine formulation composed of microspheres containing DNA-hsp65 and TDM was able to elicit a protective immune response following a single-dose administration, while naked DNA required three doses to provide the same level of protection. This microsphere-based vaccine also allowed a ten-fold reduction in the amount of plasmid administered, compared to naked DNA. In summary, this approach has great potential for increasing the effectiveness of vaccination, especially in the developing world, reducing costs and improving population coverage. We are currently investigating the duration of the immune response elicited by this new formulation and studying its mechanism of action. Tuberculosis protection by single-dose vaccine KM Lima et al
Materials and methods

Plasmid derivation
The pCDNA3-hsp65 construct was derived from the pCDNA3 vector (Invitrogen s , Carlsbad, CA, USA), previously digested with Bam HI and Not I (Gibco BRL, Gaithersburg, MD, USA); a 3.3 kb fragment, corresponding to the M. leprae hsp65 gene and the CMV intron A, was then inserted in the vector. Plasmid pCDNA3 without the hsp65 gene was used as control. DH5 a E. coli transformed with plasmid pCDNA3 or the plasmid containing the hsp65 gene (pCDNA3-hsp65) was cultured in LB liquid medium (Gibco BRL, Gaithersburg, MD, USA) containing ampicillin (100 mg/ml). The plasmids were purified using the Concert High Purity Maxiprep System (Gibco BRL, Gaithersburg, MD, USA). Plasmid concentration was determined by spectrophotometry at l ¼ 260 and 280 nm using the Gene Quant II apparatus (Pharmacia Biotech, Buckinghamshire, UK).
Microspheres preparation
Microspheres were obtained by the double emulsion/ solvent evaporation technique. Briefly, 30 ml of dichloromethane solution containing 400 mg of polymer PLGA 50:50 (Resomer RG 505, MW 78 000, from Boehringer Ingelheim, Ingelheim, Germany) and 0.5 mg of TDM (Sigma, St Louis, USA) was emulsified with 0.3 ml of an inner aqueous phase containing 4 mg of DNA (pCDNA3 or pCDNA3-hsp65) using a T50 Ultraturrax homogenizer (IKA s , Labortechnik, Germany) to produce a primary water-in-oil emulsion. This emulsion was then mixed with 100 ml of an external aqueous phase containing 3% poly (vinyl alcohol) (Mowiol s 40-88, Aldrich Chemicals, Wankee, WI, USA) as surfactant, to form a stable waterin-oil-in-water emulsion. The mixture was stirred for 6 h with a Eurostar homogenizer for solvent evaporation. Microspheres were collected and washed three times with sterile water, freeze-dried, and stored at 41C. Plasmid encapsulation rate was determined by resuspending 10 mg of microspheres in 0.2 ml of 0.1 N NaOH. Samples were incubated at 50 1C in an ultrasound bath for 2 h to allow microsphere degradation. The amount of DNA was determined as described before using Gene Quant II.
Particle diameter analysis
Particle diameter distribution was evaluated by laser diffractometry in a Cilas 1064 Liquid apparatus (Cilas, France). Results are expressed as the median value of diameter distribution.
Immunization procedures
Young adult BALB/c mice were obtained from the Animal Facilities of the School of Medicine of Ribeirão Preto, University of São Paulo, and were maintained under standard laboratory conditions. Immunization was performed by one of the following treatments, using five animals per group. For naked DNA vaccination, the plasmid carrying the hsp65 gene (pCDNA3-hsp65) was administered by intramuscular injection of 50 mg DNA in 50 ml saline into each quadriceps muscle on three occasions at 2-week intervals (total dose of 300 mg of plasmid). For DNA/TDM-loaded microspheres vaccination, mice received a single dose of an intramuscular injection of 2.5 mg of microspheres in 50 ml saline into each quadriceps muscle (total dose of 30 mg of plasmid and 6.25 mg of TDM). Additional control animals received plasmid pCDNA3 without the insert, plasmid pCDNA3-hsp65-loaded PLGA microspheres, plasmid pCDNA3/TDM-loaded PLGA microspheres, and TDMloaded microspheres.
Cytokine evaluation
Splenocytes from mice killed 2 weeks (for naked DNA) or 4 weeks (for DNA/TDM-loaded microspheres) after completion of immunization were purified by lysis of erythrocytes. Cells (5 Â 10 6 ) were stimulated in vitro with 20 mg/ml of hsp65 recombinant protein or with 40 mg/ml concanavalin A. The level of cytokine in culture supernatant was evaluated 48 h later. Capture and biotinylated monoclonal antibodies for IFN-g (R4-6A2, XMG1.2), IL-10 (JES5-2A5, SXC-1), and IL-4 (11B11, BVD6-24G2), as well as recombinant cytokines, were purchased from Pharmingen (San Diego, CA, USA). Cytokine levels were measured in culture supernatant by ELISA according to the manufacturers instructions.
Antibody evaluation
Sera from vaccinated mice were collected after completion of DNA vaccination. To assess antigen-specific antibody levels, 96-well plates (Maxisorp Nunc-Immuno plates) were coated with 0.1 ml of purified protein (5 mg/ ml) in Coating Solution (Na 2 CO 3 14.3 mM, NaHCO 3 10.3 mM, NaN 3 0.02%, pH 9.6), incubated at 41C overnight, and then blocked with 1% BSA in PBS for 60 min at 371C. Serum samples were applied in serial ten-fold dilutions from 1:10. Each serum sample represented pooled sera from three vaccinated or control mice. After incubating the plates for 2 h at 371C, anti-mouse IgG (B7022 from Sigma, St Louis, USA), biotin-conjugated IgG1 and IgG2a (A85-1 and R19-15 respectively, from Pharmingen, San Diego, CA, USA) were added for the detection of specific antibodies. After wash, plates were incubated at room temperature for 30 min with StreptAB kit (Dako, Carpinteria, CA, USA). In order to detect bound antibody, OPD substrate (Sigma, St Louis, USA) was added, and the reaction was stopped by the addition of 50 ml of a 16% solution of sulfuric acid. Optical density (OD) was measured at 490 nm. Antibodies' titer was defined as the highest dilution of serum with an absorbance value of 0.5.
RT-PCR
Total RNA was isolated from tissues by extraction in Trizol Reagent (Gibco BRL, Grand Island, NY, USA) and alcohol precipitation procedure followed by an additional treatment with Dnase I (Gibco BRL, Grand Island, NY, USA) to avoid genomic and plasmidial DNA contamination. Total RNA (10 mg) was reverse transcribed using oligo (dT) primers and reverse transcriptase (Gibco) according to the manufacturer's instructions, giving a final volume of 20 ml of cDNA preparation. PCR amplification was carried out using 3 ml of cDNA preparation and specific primer pairs of M. leprae hsp65 (sense 5 0 -ATG-GCC-AAG-ACA-ATT-GCG-TAC-3 0 ; antisense 5 0 -TTG-AGC-AGG-TCC-TCG-TAC-TCA-c-3 0 ; giving a 1.4 kb band). PCR was carried out as previously described. 19 Briefly, 50 mL of PCR mixture was prepared as follows: 0.5 mL of each 5 0 and 3 0 primer at 100 mM, 5 ml of 10 Â enzyme buffer, 0.5 ml Taq polimerase Tuberculosis protection by single-dose vaccine KM Lima et al at 5 IU/ml (Gibco BRL, Grand Island, NY, USA), 1 ml dNTP at 10 mM and 2 ml of the sample. The mixture was submitted to 30 cycles of amplification in a PTC-100 Programmable Thermal Controller (MJ Research Inc., Watertown, MA, USA). In each cycle, denaturation was at 961C for 45 seconds, annealing of primers to target cDNA was carried out at 601C for 45 s, and extension was at 721C for 90 s. Messenger RNA for b-actin was detected by PCR using 2 ml of cDNA and b-actin-specific primers (sense 5 0 -GTG-GGC-CGC-TCT-AGG-CAC-CAA-3 0 ; antisense 5 0 -CTC-TTT-GAT-GTC-ACG-CAC-GAT-TTC-3 0 ; giving a 902 bp band). PCR products were visualized by ultraviolet illumination after electrophoresis in 0.8% agarose gel containing ethidium bromide.
Histological evaluation
For evaluation of the histological reaction at the injection site, immunized mice were killed 5 and 30 days after administration of microspheres. The administration site was removed, fixed on buffered formaldehyde solution, and submitted for histological analysis.
M. tuberculosis challenge
The mice were challenged by intratracheal route with 10 5 CFU of M. tuberculosis H37Rv, 15 days after the third immunization. Thirty days after challenge, the mice were killed and serial ten-fold dilutions of lung homogenate were plated on 7H11 Mildebrook agar medium supplemented with 10% of fetal calf serum. Petri dishes were incubated for 4 weeks at 371C, and colonies were counted visually. Results are expressed as mean log 10 values per group. Cytokine levels were measured in homogenate of bulk lung cells by ELISA.
Statistical analysis
Results were expressed as mean 7 s.d. Significance of the difference among groups was calculated by ANOVA followed by Tukey's multiple comparison test. Computer-assisted evaluation of the results was used to calculate the probability value in the data. A P-value of 0.05 was used as the limit of statistical significance. Data are representative of two independent experiments.
